Showing results (201-210 of 604) with videos related to

Sort By:
Pageof 61
European Journal of Internal Medicine|May 11, 2021
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseasesPaul Decker, Thomas Moulinet, Benjamin Lopez, et al.
The Journal of Rheumatology|March 17, 2020
Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective StudyVincent Langlois, André Gillibert, Yurdagül Uzunhan, et al.
Arthritis Research & Therapy|March 8, 2007
CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndromeJacques-Eric Gottenberg, Pascale Loiseau, Mariam Azarian, et al.
Nature Reviews. Rheumatology|January 26, 2026
Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosisJörg H W Distler, David Launay, Carol Feghali-Bostwick, et al.
Medicine|September 3, 2004
Neurologic manifestations in primary Sjögren syndrome: a study of 82 patientsSophie Delalande, Jérôme de Seze, Anne-Laure Fauchais, et al.
Arthritis and Rheumatism|July 1, 2009
The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndromeCorinne Miceli-Richard, Nicolas Gestermann, Marc Ittah, et al.
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findingsFrancis Juthier, Pierre V Ennezat, Paul Fornes, et al.
Proteomics. Clinical Applications|September 3, 2024
Analysis of Unfolded Protein Response Activation in Colon Adenocarcinoma Epithelial Cells: A Proteomic StudySolange Vivier, Fabrice Bray, Stéphanie Flament, et al.
Medicine|July 2, 2015
Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and OutcomesCéline Dieval, Christophe Deligny, Alain Meyer, et al.
Pageof 61